These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28387350)

  • 1. Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice.
    Chen YH; Wu KJ; Wu KL; Wu KL; Tsai HM; Chen ML; Chen YW; Hsieh W; Lin CM; Wang Y
    Sci Rep; 2017 Apr; 7():46301. PubMed ID: 28387350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
    Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
    J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
    Hay CE; Gonzalez GA; Ewing LE; Reichard EE; Hambuchen MD; Nanaware-Kharade N; Alam S; Bolden CT; Owens SM; Margaritis P; Peterson EC
    PLoS One; 2018; 13(6):e0200060. PubMed ID: 29958300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice.
    Yan Y; Miyamoto Y; Nitta A; Muramatsu S; Ozawa K; Yamada K; Nabeshima T
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1559-67. PubMed ID: 23432945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
    Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
    J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of active and passive human vaccines to treat methamphetamine addiction.
    Gentry WB; Rüedi-Bettschen D; Owens SM
    Hum Vaccin; 2009 Apr; 5(4):206-13. PubMed ID: 19276653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.
    Peterson EC; Gunnell M; Che Y; Goforth RL; Carroll FI; Henry R; Liu H; Owens SM
    J Pharmacol Exp Ther; 2007 Jul; 322(1):30-9. PubMed ID: 17452421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice.
    He Z; Yan L; Yong Z; Dong Z; Dong H; Gong Z
    Behav Brain Res; 2013 Feb; 239():172-6. PubMed ID: 23159705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.
    Harris AC; LeSage MG; Shelley D; Perry JL; Pentel PR; Owens SM
    PLoS One; 2015; 10(3):e0118787. PubMed ID: 25742165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
    Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
    Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.
    Laurenzana EM; Byrnes-Blake KA; Milesi-Hallé A; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2003 Nov; 31(11):1320-6. PubMed ID: 14570763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines.
    Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD
    Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period.
    Hambuchen MD; Rüedi-Bettschen D; Williams DK; Hendrickson H; Owens SM
    Vaccine; 2014 Oct; 32(47):6213-9. PubMed ID: 25252196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of antibody-based immunotherapy for methamphetamine abuse: immunization, and virus-mediated gene transfer approaches.
    Chen YH; Chen CH
    Curr Gene Ther; 2013 Feb; 13(1):39-50. PubMed ID: 23157545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
    Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
    Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
    Reichard EE; Nanaware-Kharade N; Gonzalez GA; Thakkar S; Owens SM; Peterson EC
    Pharm Res; 2016 Dec; 33(12):2954-2966. PubMed ID: 27620175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a passive immunity mouse model to quantitatively analyze the impact of neutralizing antibodies on adeno-associated virus-mediated gene transfer.
    Sun L; Tu L; Gao G; Sun X; Duan J; Lu Y
    J Immunol Methods; 2013 Jan; 387(1-2):114-20. PubMed ID: 23063691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-Mediated In Vivo Antibody Expression.
    Schnepp BC; Johnson PR
    Microbiol Spectr; 2014 Aug; 2(4):AID-0016-2014. PubMed ID: 26104192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats.
    Byrnes-Blake KA; Carroll FI; Abraham P; Owens SM
    Int Immunopharmacol; 2001 Feb; 1(2):329-38. PubMed ID: 11360933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.